PATIENT PREFERENCES FOR PHARMACEUTICAL AND INTERVENTIONAL HYPERTENSION TREATMENTS: RESULTS FROM A DISCRETE CHOICE EXPERIMENT.

Atul Pathak,Michael Weber,Christine Poulos,Joshua Coulter,Sidney Cohen,Vanessa Debruin,Denise Jones,David Kandzari

Journal of hypertension（2022）

引用 0|浏览10

暂无评分

摘要

Among U.S. patients with HTN, a DCE study demonstrated that BP reduction was the most important driver of choice, risks were less important, and a minimal BP reduction was sufficient to offset treatment risks associated with an interventional procedure like RDN.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要